Virtual Reality in COPD Exacerbation

Launched by PAMUKKALE UNIVERSITY · Jan 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how virtual reality can help patients who are hospitalized due to a worsening of their Chronic Obstructive Pulmonary Disease (COPD). COPD can make it hard to breathe, and this study is looking at whether using virtual reality during hospital stays, along with standard rehabilitation exercises, can improve patients' recovery more effectively in a shorter time.

To participate, individuals must be experiencing a COPD exacerbation, which means their symptoms have gotten worse, and they must have certain lung function levels. Eligible participants are usually between the ages of 65 and 74 and should be willing to join the study. However, those with more serious respiratory issues or certain heart conditions, among other health concerns, will not be included. If you join the study, you can expect to use virtual reality technology alongside your regular treatment to see if it helps improve your recovery experience.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals who are in COPD exacerbation period, FEV1 \<70%, GOLD 2-3 spirometric stage, Hodkinson mental test score \> 6 and who want to participate in the study voluntarily will be included in the study.
• Exclusion Criteria:
• • If there is respiratory disease considered more significant than COPD (bronchiectasis, lung cancer requiring active therapy, or asthma), Heart failure New York Heart Association (NYHA) stage 3-4, Significant hemoptysis, surgical or non-surgical lung volume in the past 6 months Individuals with reduction procedures, Lung transplantation or pneumonectomy surgery in the last 6 months, pulmonary embolism or pulmonary edema, acute myocardial infarction, acute heart failure, vertigo, epilepsy and visual impairment will be excluded from the study.